Related Documents
-
Notice: Meetings: Pediatric studies; medical and clinical pharmacology review summaries
88 reads -
Notice: Human drugs:
New drug applications— Penthrane (methoxyflurane) Inhalation Liquid, 99.9 percent; approval withdrawn
98 reads -
Notice: Human drugs:
New drug applications— Premarket approval applications; list; safety and effectiveness summaries’ availability
111 reads -
Notice: Meetings: Science Board
61 reads -
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee
87 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Pediatric studies; medical and clinical pharmacology reviews; summaries
121 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— ACIPHEX (rabeprazol sodium)
73 reads -
DRUG
294 reads -
lechu
33 reads -
Notice: Human drugs:
Best Pharmaceuticals for Children Act— ALOXI
61 reads -
Notice: Harmonisation International Conference; guidelines availability: Biotechnological/biological products; Q5E comparability subject to changes in manufacturing process
80 reads -
Drug Approval Trends at the FDA and EMEA: Process improvements
2252 reads -
Notice: Harmonisation International Conference; guidelines availability: ZYVOX (linezolid) tablets, 400 milligrams
87 reads -
Notice: Human drugs:
Best Pharmaceuticals for Children Act— Pediatric studies; referral of KEMSTRO and DROXIA to Foundation for National Institutes of Health
417 reads -
Notice: Human drugs:
New drug applications— High Chemical Co., et al. approval withdrawn
34 reads -
Notice: Committees; establishment, renewal, termination, etc.: CollaGenex Pharmaceuticals, Inc., approval withdrawn
71 reads -
Notice: Medical devices:
Patent extension; regulatory review period determinations— Pediatric studies; medical and clinical pharmacology reviews; summaries
80 reads -
Notice: Meetings: Oncologic Drugs Advisory Committee; correction
45 reads -
Notice: Meetings: Prescription Drug User Fee Act; correction
37 reads -
Notice: Harmonisation International Conference; guidelines availability: Blood Products Advisory Committee
40 reads
Related Documents
Flag this document
1 Page
